뉴스/Reuters/Teva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System AtrophyTeva’S Emrusolmin Granted U.S. FDA Fast Track Designation For Treatment Of Multiple System AtrophyRefinitiv1분 미만 읽기TEVATeva Pharmaceutical Industries Ltd TEVA:TEVA’S EMRUSOLMIN GRANTED U.S. FDA FAST TRACK DESIGNATION FOR TREATMENT OF MULTIPLE SYSTEM ATROPHYReuters미국 주식이스라엘 주식© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html더 보기이 뉴스를 읽으려면 로그인하거나 평생 무료 계정을 만드십시오렛츠고
